Use of paclitaxel for advanced ovarian cancer in clinical practice: analysis of 541 patients. Results from a German multi-centre observational study.
Sehouli
J
J
Department of Gynecology and Obstetrics, Charité/Campus Virchow-Klinikum, University of Berlin, Berlin, Germany. sehouli@aol.com
Oskay-Ozcelik
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D005260:Female; D058006:General Practice; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D055815:Young Adult
D016190:Carboplatin; D017239:Paclitaxel